GSK-3b in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1– dependent mechanism

Glycogen synthase kinase–3 (GSK-3) is a widely expressed and highly conserved serine/threonine protein kinase encoded by 2 genes, GSK3A and GSK3B. GSK-3 is thought to be involved in tissue repair and fibrogenesis, but its role in these processes is currently unknown. To investigate the function of GSK-3b in fibroblasts, we generated mice harboring a fibroblast-specific deletion of Gsk3b and evaluated their wound-healing and fibrogenic responses. We have shown that Gsk3b-conditional-KO mice (Gsk3b-CKO mice) exhibited accelerated wound closure, increased fibrogenesis, and excessive scarring compared with control mice. In addition, Gsk3b-CKO mice showed elevated collagen production, decreased cell apoptosis, elevated levels of profibrotic a-SMA, and increased myofibroblast formation during wound healing. In cultured Gsk3b-CKO fibroblasts, adhesion, spreading, migration, and contraction were enhanced. Both Gsk3b-CKO mice and fibroblasts showed elevated expression and production of endothelin-1 (ET-1) compared with control mice and cells. Antagonizing ET-1 reversed the phenotype of Gsk3b-CKO fibroblasts and mice. Thus, GSK-3b appears to control the progression of wound healing and fibrosis by modulating ET1 levels. These results suggest that targeting the GSK-3b pathway or ET-1 may be of benefit in controlling tissue repair and fibrogenic responses in vivo. Research Article Dermatology

[1]  A. Leask Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. , 2008, Cellular signalling.

[2]  M. Permutt,et al.  Genetic Deficiency of Glycogen Synthase Kinase-3β Corrects Diabetes in Mouse Models of Insulin Resistance , 2008, PLoS biology.

[3]  Shaoqiong Chen,et al.  The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts , 2007, Journal of Cell Communication and Signaling.

[4]  K. Lyons,et al.  CTGF(CCN2) is essential for fibroblast function , 2006 .

[5]  B. Alman,et al.  Prolonged β-catenin stabilization and tcf-dependent transcriptional activation in hyperplastic cutaneous wounds , 2005, Laboratory Investigation.

[6]  M. Clozel,et al.  Role of endothelin in fibrosis and anti‐fibrotic potential of bosentan , 2005, Annals of medicine.

[7]  B. Doble,et al.  Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword? , 2004, Biochemical Society transactions.

[8]  Yunliang Chen,et al.  Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. , 2004, Molecular biology of the cell.

[9]  Michael Koutsilieris,et al.  The Akt pathway: molecular targets for anti-cancer drug development. , 2004, Current cancer drug targets.

[10]  D. Abraham,et al.  Col1a2 enhancer regulates collagen activity during development and in adult tissue repair. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[11]  G. Gabbiani,et al.  The myofibroblast in wound healing and fibrocontractive diseases , 2003, The Journal of pathology.

[12]  B. Doble,et al.  GSK-3: tricks of the trade for a multi-tasking kinase , 2003, Journal of Cell Science.

[13]  C. Denton,et al.  Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis. , 2002, The American journal of pathology.

[14]  Hans Clevers,et al.  β-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Alman,et al.  Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). , 1997, The American journal of pathology.

[16]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[17]  C. Enwemeka,et al.  A simplified method for the analysis of hydroxyproline in biological tissues. , 1996, Clinical biochemistry.

[18]  H. Stegemann,et al.  Determination of hydroxyproline. , 1967, Clinica chimica acta; international journal of clinical chemistry.

[19]  Hui Xiong,et al.  beta-Catenin activates the growth factor endothelin-1 in colon cancer cells. , 2005, Oncogene.

[20]  T. Krieg,et al.  Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis , 2004, Springer Seminars in Immunopathology.

[21]  R. Nusse,et al.  Convergence of Wnt, beta-catenin, and cadherin pathways. , 2004, Science.

[22]  J. Woodgett,et al.  Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. , 2000, Nature.

[23]  S. Byers,et al.  Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. , 1997, The Journal of biological chemistry.

[24]  R Kemler,et al.  beta-catenin is a target for the ubiquitin-proteasome pathway. , 1997, The EMBO journal.

[25]  R Grosschedl,et al.  Functional interaction of beta-catenin with the transcription factor LEF-1. , 1996, Nature.